ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2020 Pediatric Rheumatology Symposium

April 29-May 2, 2020

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

View by Number View by Title View Sessions
View by Date

Saturday, May 2, 2020

4:15PM-5:15PM
Abstract Number: 181
Health Care Professionals and Transition to Adulthood for Youth with Juvenile Idiopathic Arthritis
Poster Session 3
4:15PM-5:15PM
Abstract Number: 146
Immersive Virtual Reality for Management of Amplified Musculoskeletal Pain Syndrome in Adolescents: A Pilot Randomized Controlled Trial
Poster Session 3
4:15PM-5:15PM
Abstract Number: 143
Immunological Profiles Following Treatment with Rituximab in Autoimmune Disease
Poster Session 3
4:15PM-5:15PM
Abstract Number: 161
Impact of the Month of Birth on the Development of Juvenile Idiopathic Arthritis in the United States
Poster Session 3
4:15PM-5:15PM
Abstract Number: 189
Influenza Immunization: A Quality Assurance Survey in a Pediatric Rheumatology Clinic
Poster Session 3
4:15PM-5:15PM
Abstract Number: 180
Influenza Knowledge and Barriers to Vaccination in Immunosuppressed Patients in the Pediatric Rheumatology Clinic
Poster Session 3
4:15PM-5:15PM
Abstract Number: 159
Interleukin-18 as a Key Cytokine to Understand Pathology and to Decide Appropriate Therapeutic Strategy in Chronic Arthritic Systemic Juvenile Idiopathic Arthritis
Poster Session 3
4:15PM-5:15PM
Abstract Number: 123
Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: High Biologic Use, Low Prevalence of HLA-B27, and Equal Sex Representation in Those with Sacroiliitis
Poster Session 3
4:15PM-5:15PM
Abstract Number: 167
Lipidomic Profiles of Synovial Fluid from Patients with Oligoarticular Juvenile Idiopathic Arthritis Naïve to Treatment
Poster Session 3
4:15PM-5:15PM
Abstract Number: 118
Long-Term Outcomes in Children Born to Anti-Ro and/or anti-La Positive Mothers
Poster Session 3
4:15PM-5:15PM
Abstract Number: 137
Measuring Decision Conflict in Parents of Children with Juvenile Idiopathic Arthritis When Making the Decision to Begin Disease Modifying Anti-Rheumatic Drugs or Biologic Agents
Poster Session 3
4:15PM-5:15PM
Abstract Number: 162
Minor Biomarkers in Juvenile Idiopathic Arthritis (JIA)
Poster Session 3
4:15PM-5:15PM
Abstract Number: 114
Musculoskeletal Ultrasound Study in Childhood Arthritis: A Limited Examination
Poster Session 3
4:15PM-5:15PM
Abstract Number: 182
Needs of Youth with Juvenile Idiopathic Arthritis During the Transition to Adulthood
Poster Session 3
4:15PM-5:15PM
Abstract Number: 179
New Juvenile Idiopathic Arthritis Quality Measure Set for the Pediatric Rheumatology Care and Outcomes Improvement Network
Poster Session 3
  • «Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology